Symbols / TIVC Stock $0.96 -4.00%
TIVC (Stock) Chart
About
Asset: Stock
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 2.42M |
| Enterprise Value | -1.75M | Income | -7.55M | Sales | 482.00K |
| Book/sh | 3.36 | Cash/sh | 1.95 | Dividend Yield | — |
| Payout | 0.00% | Employees | 7 | IPO | — |
| P/E | — | Forward P/E | -0.04 | PEG | — |
| P/S | 5.03 | P/B | 0.29 | P/C | — |
| EV/EBITDA | 0.24 | EV/Sales | -3.64 | Quick Ratio | 5.44 |
| Current Ratio | 5.86 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -8.00 | EPS next Y | -24.00 | EPS Growth | — |
| Revenue Growth | 15.90% | Earnings | 2023-11-14 16:00 | ROA | -96.20% |
| ROE | -178.18% | ROIC | — | Gross Margin | -58.09% |
| Oper. Margin | -17.01% | Profit Margin | 0.00% | Shs Outstand | 2.53M |
| Shs Float | 1.53M | Short Float | 1.37% | Short Ratio | 0.65 |
| Short Interest | — | 52W High | 13.23 | 52W Low | 0.72 |
| Beta | 2.01 | Avg Volume | 1.08M | Volume | 64.14K |
| Target Price | — | Recom | None | Prev Close | $1.00 |
| Price | $0.96 | Change | -4.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.96
Latest analyst target
3. DCF / Fair value
$-25.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.96
Low
—
High
—
Mean
—
- Tivic Health Consolidates Headquarters at New San Antonio Campus - The Globe and Mail Sat, 14 Mar 2026 21
- Biotech leader behind 17 drug launches now steering Tivic’s biopharma pivot - Stock Titan Wed, 04 Mar 2026 08
- Tivic Health Systems enters new facility leases and relocates headquarters - Investing.com Fri, 13 Mar 2026 22
- Velocity Bioworks: A Game-Changer for TIVC? - timothysykes.com ue, 23 Dec 2025 08
- TIVC - Tivic Health Systems Inc Latest Stock News & Market Updates - Stock Titan Sun, 22 Feb 2026 17
- Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital - TradingView Mon, 09 Feb 2026 08
- These stocks have an unusual volume in today's session - ChartMill Wed, 11 Mar 2026 18
- TIVC PE Ratio & Valuation, Is TIVC Overvalued - Intellectia AI Sat, 28 Feb 2026 00
- Tivic Health Systems, Inc. Files Form 8-K with SEC for Special Stockholder Meeting – March 11, 2026 - Minichart hu, 12 Mar 2026 08
- Tivic Health Cancels Shareholder Meeting and Withdraws Proposals - TipRanks hu, 12 Mar 2026 00
- Tivic Health (Nasdaq: TIVC) adds CDMO unit to speed Entolimod manufacturing - Stock Titan hu, 11 Dec 2025 08
- Tivic Health Appoints New CEO to Drive Biopharma Pivot - TipRanks Wed, 04 Mar 2026 08
- Tivic to detail in-house Entolimod manufacturing, new revenue streams - Stock Titan ue, 20 Jan 2026 08
- 3i affiliates report 9.99% stake in Tivic Health (NASDAQ: TIVC) - Stock Titan Fri, 27 Feb 2026 08
- Tivic Health Highlights TLR5 Pipeline in New Investor Presentation - TipRanks ue, 20 Jan 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8824 | — | — | HANDLEY MICHAEL K | Chief Operating Officer | — | 2026-02-18 00:00:00 | D | nan |
| 1 | 736 | — | — | WOLF LISA G | Chief Financial Officer | — | 2025-12-18 00:00:00 | D | nan |
| 2 | 14706 | — | — | ERNST JENNIFER | Chief Executive Officer | — | 2025-12-18 00:00:00 | D | nan |
| 3 | 22541 | — | Stock Award(Grant) at price 0.00 per share. | ERNST JENNIFER | Chief Executive Officer | — | 2025-09-22 00:00:00 | D | — |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.31M | -8.06M | -9.92M | -5.45M |
| TotalUnusualItems | 0.00 | -1.20M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | -1.20M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -5.66M | -8.24M | -10.10M | -8.49M |
| ReconciledDepreciation | 352.00K | 182.00K | 174.00K | 24.00K |
| ReconciledCostOfRevenue | 778.00K | 889.00K | 1.54M | 1.29M |
| EBITDA | -5.31M | -8.06M | -9.92M | -6.65M |
| EBIT | -5.66M | -8.24M | -10.10M | -6.67M |
| NetInterestIncome | 6.00K | 1.00K | 2.00K | -1.82M |
| InterestExpense | 1.82M | |||
| InterestIncome | 6.00K | 1.00K | 2.00K | |
| NormalizedIncome | -5.66M | -8.24M | -10.10M | -7.29M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -5.66M | -8.24M | -10.10M | -8.49M |
| TotalExpenses | 6.44M | 9.42M | 11.94M | 6.89M |
| TotalOperatingIncomeAsReported | -5.66M | -8.24M | -10.10M | -5.63M |
| DilutedAverageShares | 287.37K | 46.65K | 5.69K | 2.05K |
| BasicAverageShares | 287.37K | 46.65K | 5.69K | 2.05K |
| DilutedEPS | -19.68 | -176.80 | -1.77K | -4.13K |
| BasicEPS | -19.68 | -176.80 | -1.77K | -4.13K |
| DilutedNIAvailtoComStockholders | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeCommonStockholders | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncome | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeIncludingNoncontrollingInterests | -5.66M | -8.24M | -10.10M | -8.49M |
| NetIncomeContinuousOperations | -5.66M | -8.24M | -10.10M | -8.49M |
| TaxProvision | 1.00K | |||
| PretaxIncome | -5.66M | -8.24M | -10.10M | -8.49M |
| OtherIncomeExpense | -1.04M | |||
| OtherNonOperatingIncomeExpenses | 162.00K | |||
| SpecialIncomeCharges | 0.00 | -1.64M | ||
| OtherSpecialCharges | 1.64M | |||
| GainOnSaleOfSecurity | 436.00K | |||
| NetNonOperatingInterestIncomeExpense | 6.00K | 1.00K | 2.00K | -1.82M |
| TotalOtherFinanceCost | -2.00K | |||
| InterestExpenseNonOperating | 1.82M | |||
| InterestIncomeNonOperating | 6.00K | 1.00K | 2.00K | |
| OperatingIncome | -5.66M | -8.24M | -10.10M | -5.63M |
| OperatingExpense | 5.66M | 8.53M | 10.40M | 5.59M |
| ResearchAndDevelopment | 1.31M | 1.66M | 1.73M | 878.00K |
| SellingGeneralAndAdministration | 4.35M | 6.88M | 8.67M | 4.72M |
| SellingAndMarketingExpense | 1.19M | 2.12M | 2.79M | 1.79M |
| GeneralAndAdministrativeExpense | 3.16M | 4.75M | 5.88M | 2.93M |
| OtherGandA | 3.16M | 4.75M | 5.88M | 2.93M |
| GrossProfit | 2.00K | 287.00K | 299.00K | -38.00K |
| CostOfRevenue | 778.00K | 889.00K | 1.54M | 1.29M |
| TotalRevenue | 780.00K | 1.18M | 1.84M | 1.26M |
| OperatingRevenue | 780.00K | 1.18M | 1.84M | 1.26M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 556.98K | 86.24K | 5.69K | 5.71K |
| ShareIssued | 556.98K | 86.24K | 5.69K | 5.71K |
| TotalDebt | 0.00 | 369.00K | 530.00K | 708.00K |
| TangibleBookValue | 2.54M | 3.58M | 3.63M | 13.27M |
| InvestedCapital | 2.54M | 3.58M | 3.63M | 13.27M |
| WorkingCapital | 2.37M | 3.25M | 3.43M | 13.07M |
| NetTangibleAssets | 2.54M | 3.58M | 3.63M | 13.27M |
| CapitalLeaseObligations | 0.00 | 369.00K | 530.00K | 708.00K |
| CommonStockEquity | 2.54M | 3.58M | 3.63M | 13.27M |
| TotalCapitalization | 2.54M | 3.58M | 3.63M | 13.27M |
| TotalEquityGrossMinorityInterest | 2.54M | 3.58M | 3.63M | 13.27M |
| StockholdersEquity | 2.54M | 3.58M | 3.63M | 13.27M |
| RetainedEarnings | -43.54M | -37.89M | -29.64M | -19.55M |
| AdditionalPaidInCapital | 46.08M | 41.47M | 33.27M | 32.82M |
| CapitalStock | 1.00K | 0.00 | 0.00 | 1.00K |
| CommonStock | 1.00K | 0.00 | 0.00 | 1.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 272.00K | 1.58M | 2.25M | 1.76M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 176.00K | 367.00K | 545.00K |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 176.00K | 367.00K | 545.00K |
| LongTermCapitalLeaseObligation | 0.00 | 176.00K | 367.00K | 545.00K |
| CurrentLiabilities | 272.00K | 1.40M | 1.88M | 1.22M |
| CurrentDebtAndCapitalLeaseObligation | 193.00K | 163.00K | 163.00K | |
| CurrentCapitalLeaseObligation | 0.00 | 193.00K | 163.00K | 163.00K |
| PayablesAndAccruedExpenses | 272.00K | 1.21M | 1.72M | 1.06M |
| CurrentAccruedExpenses | 147.00K | 335.00K | 392.00K | 267.00K |
| Payables | 125.00K | 873.00K | 1.32M | 789.00K |
| TotalTaxPayable | 0.00 | 160.00K | ||
| AccountsPayable | 125.00K | 713.00K | 1.32M | 789.00K |
| TotalAssets | 2.81M | 5.16M | 5.88M | 15.04M |
| TotalNonCurrentAssets | 168.00K | 505.00K | 569.00K | 747.00K |
| OtherNonCurrentAssets | 34.00K | 34.00K | 49.00K | |
| NonCurrentDeferredAssets | 49.00K | 0.00 | ||
| NetPPE | 119.00K | 471.00K | 535.00K | 698.00K |
| AccumulatedDepreciation | -40.00K | -37.00K | -29.00K | |
| GrossPPE | 159.00K | 508.00K | 564.00K | 698.00K |
| OtherProperties | 148.00K | 148.00K | 30.00K | 11.00K |
| MachineryFurnitureEquipment | 11.00K | 11.00K | 11.00K | |
| BuildingsAndImprovements | 0.00 | 349.00K | 523.00K | 687.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.64M | 4.65M | 5.31M | 14.29M |
| OtherCurrentAssets | 249.00K | 327.00K | 235.00K | 793.00K |
| CurrentDeferredAssets | 0.00 | 584.00K | 0.00 | |
| PrepaidAssets | 834.00K | |||
| Inventory | 319.00K | 756.00K | 863.00K | 429.00K |
| InventoriesAdjustmentsAllowances | -338.00K | -32.00K | 0.00 | 0.00 |
| FinishedGoods | 192.00K | 36.00K | 116.00K | 148.00K |
| WorkInProcess | 5.00K | 0.00 | 23.00K | 0.00 |
| RawMaterials | 460.00K | 752.00K | 724.00K | 281.00K |
| Receivables | 69.00K | 174.00K | 107.00K | 92.00K |
| AccountsReceivable | 69.00K | 174.00K | 107.00K | 92.00K |
| AllowanceForDoubtfulAccountsReceivable | 0.00 | -82.00K | ||
| GrossAccountsReceivable | 88.00K | 174.00K | ||
| CashCashEquivalentsAndShortTermInvestments | 2.00M | 3.40M | 3.52M | 12.97M |
| CashAndCashEquivalents | 2.00M | 3.40M | 3.52M | 12.97M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.72M | -8.63M | -8.93M | -5.61M |
| RepaymentOfDebt | 0.00 | -19.00K | ||
| IssuanceOfDebt | 0.00 | 2.61M | ||
| IssuanceOfCapitalStock | 4.38M | 8.51M | 0.00 | 14.89M |
| CapitalExpenditure | -118.00K | -11.00K | ||
| InterestPaidSupplementalData | 0.00 | |||
| IncomeTaxPaidSupplementalData | 1.00K | |||
| EndCashPosition | 2.00M | 3.40M | 3.52M | 12.97M |
| BeginningCashPosition | 3.40M | 3.52M | 12.97M | 1.04M |
| ChangesInCash | -1.39M | -122.00K | -9.46M | 11.93M |
| FinancingCashFlow | 4.33M | 8.51M | -528.00K | 17.54M |
| CashFlowFromContinuingFinancingActivities | 4.33M | 8.51M | -528.00K | 17.54M |
| NetOtherFinancingCharges | -49.00K | -584.00K | ||
| ProceedsFromStockOptionExercised | 0.00 | 56.00K | 62.00K | |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 4.38M | 8.51M | 0.00 | 14.89M |
| CommonStockIssuance | 4.38M | 8.51M | 0.00 | 14.89M |
| NetIssuancePaymentsOfDebt | 0.00 | 2.59M | ||
| NetLongTermDebtIssuance | 0.00 | 2.59M | ||
| LongTermDebtPayments | 0.00 | -19.00K | ||
| LongTermDebtIssuance | 0.00 | 2.61M | ||
| InvestingCashFlow | 0.00 | -118.00K | -11.00K | 0.00 |
| CashFlowFromContinuingInvestingActivities | 0.00 | -118.00K | -11.00K | 0.00 |
| NetPPEPurchaseAndSale | 0.00 | -118.00K | -11.00K | 0.00 |
| PurchaseOfPPE | 0.00 | -118.00K | -11.00K | 0.00 |
| OperatingCashFlow | -5.72M | -8.51M | -8.92M | -5.61M |
| CashFlowFromContinuingOperatingActivities | -5.72M | -8.51M | -8.92M | -5.61M |
| ChangeInWorkingCapital | -1.00M | -752.00K | 605.00K | -403.00K |
| ChangeInOtherCurrentLiabilities | -369.00K | -161.00K | -178.00K | 4.00K |
| ChangeInOtherCurrentAssets | 34.00K | 0.00 | 15.00K | 0.00 |
| ChangeInPayablesAndAccruedExpense | -936.00K | -507.00K | 643.00K | 547.00K |
| ChangeInAccruedExpense | -348.00K | 103.00K | 109.00K | 128.00K |
| ChangeInPayable | -588.00K | -610.00K | 534.00K | 419.00K |
| ChangeInAccountPayable | -588.00K | -610.00K | 534.00K | 419.00K |
| ChangeInPrepaidAssets | 78.00K | -92.00K | 558.00K | -707.00K |
| ChangeInInventory | 83.00K | 75.00K | -434.00K | -181.00K |
| ChangeInReceivables | 105.00K | -67.00K | 1.00K | -66.00K |
| ChangesInAccountReceivables | 105.00K | -67.00K | 1.00K | -66.00K |
| OtherNonCashItems | 1.82M | |||
| StockBasedCompensation | 229.00K | 271.00K | 398.00K | 57.00K |
| ProvisionandWriteOffofAssets | 354.00K | 32.00K | 0.00 | 58.00K |
| DepreciationAmortizationDepletion | 352.00K | 182.00K | 174.00K | 24.00K |
| DepreciationAndAmortization | 352.00K | 182.00K | 174.00K | 24.00K |
| Depreciation | 352.00K | 182.00K | 174.00K | 24.00K |
| OperatingGainsLosses | 1.32M | |||
| GainLossOnInvestmentSecurities | -156.00K | |||
| NetIncomeFromContinuingOperations | -5.66M | -8.24M | -10.10M | -8.49M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for TIVC
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|